Prescott, Ariz. -- Imulan BioTherapeutics launched a new clinical Web site to complement its comparative research and clinical trial program.
Prescott, Ariz.
-- Imulan BioTherapeutics launched a new clinical
Web site
to complement its comparative research and clinical trial program.
The site will provide information about future and ongoing Imulan clinical trials.
Information currently is available for trials of three immune regulatory technologies for veterinary medicine.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
dvm360 announces winners of the Veterinary Heroes program
Published: September 6th 2024 | Updated: November 5th 2024This year’s event is supported by corporate sponsor Schwarzman Animal Medical Center and category sponsors Blue Buffalo Natural, MedVet, Banfield Pet Hospital, Thrive Pet Healthcare and PRN Pharmacal.
Read More